Clinical Trials
Avance Clinical Client Atossa Therapeutics Announces Final Results from Phase 1 Clinical Study Showing Safety and Tolerability of AT-301 Nasal Spray Being Developed for...
The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical congratulated Atossa Therapeutics on the announcement of their Phase 1 final results for the AT-301 nasal spray being developed for COVID-19.
Atossa...
News
Contamination and Risk Management within the Pharmaceutical Sector
Given that the pharmaceutical industry is inherently linked with healthcare and wellness, ensuring high cleanliness standards and that any risks are identified and addressed is vital – the lives of civilians depend upon it. This means that extensive protocols...
News
Baxter to Provide Fill/Finish and Packaging Services for Moderna’s COVID-19 Vaccine
Baxter International Inc., a global leader in sterile medication production and delivery, and Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that they have entered into an agreement for Baxter BioPharma Solutions to provide...
News
Jubilant HollisterStier Signs Manufacturing Agreement with Eli Lilly for COVID-19 Therapeutic Bamlanivimab
Jubilant Life Sciences Ltd, an integrated global Pharmaceuticals and Life Sciences Company, recently announced that its wholly-owned subsidiary, Jubilant Pharma Limited, through one of its subsidiaries, Jubilant HollisterStier LLC , has signed new contract with Eli Lilly for contract...
News
Swiss company to produce Russian Sputnik coronavirus vaccine in Italy
The Russian Direct Investment Fund (RDIF) is set to cooperate with Swiss-based Adienne Pharma & Biotech for Sputnik V coronavirus vaccine production in Italy, chief executive of RDIF Kirill Dmitriev said.
"We are holding talks with the government of Italy....
News
Lilly and Biolojic Design Announce Research Collaboration to Discover and Develop Antibody Therapies for Diabetes
Eli Lilly and Company and Biolojic Design Ltd., a biotechnology company that computationally designs functional antibodies, announced a research collaboration and license agreement that will leverage Biolojic's AI-based multibody platform to discover and develop a potential novel antibody-based therapy...
News
Johnson & Johnson COVID-19 Vaccine Granted Authorization under Interim Order by Health Canada For Emergency Use
Johnson & Johnson announced that Health Canada has granted an Interim Order (IO) authorization for its single-shot COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, to prevent COVID-19 in individuals 18 years of age and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read